PARP1 and hepatocellular carcinoma: For example, in hepatocellular carcinoma (HCC) the lncRNA lncPARP1, which was significantly up-regulated in HCC patients, directly increased the expression of its target PARP1 acting in cis, thus triggering genomic instability and disease progression [35].